| 产品描述: | ATC0175 是一种有效的、选择性和口服活性的黑色素浓缩激素 1 受体拮抗剂,MCH1R 和 MCH2R 的 IC50s 分别为 13.5,>10000 nM。ATC0175 在动物模型中显示出抗抑郁作用和抗焦虑作用。ATC0175 具有研究抑郁症和/或焦虑症的潜力。 |
| 靶点: |
IC50: 13.5 nM (MCH1R); >10000 nM (MCH2R). |
| 体外研究: |
ATC0175 shows affinity for 5-HT2B and 5-HT1A with IC50s of 9.66 and 16.9 nM respectively. |
| 体内研究: |
ATC0175 (1, 3, 10 mg/kg; p.o.) significantly and dose-dependently reduces immobility time, indicating antidepressant like potential. |
| 参考文献: |
1. Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y. ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety. CNS Drug Rev. 2005 Winter;11(4):341-52. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.165 ml |
10.824 ml |
21.648 ml |
| 5 mM |
0.433 ml |
2.165 ml |
4.33 ml |
| 10 mM |
0.216 ml |
1.082 ml |
2.165 ml |
| 50 mM |
0.043 ml |
0.216 ml |
0.433 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |